Anzeige
Mehr »
Login
Samstag, 04.05.2024 Börsentäglich über 12.000 News von 685 internationalen Medien
InnoCan Pharma: Multi-Milliarden-Wert in diesem Pennystock?!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
462 Leser
Artikel bewerten:
(0)

Law Offices of John David Hart: DePuy Recalled Hip Device Lawsuit Filed by Houston Woman / Houston, Texas woman's DePuy ASR XL hip implants fail in both hips

HOUSTON, March 25, 2011 /PRNewswire/ -- Raylene Riha and her husband, Michael, filed suit today against DePuy Orthopaedics, Inc. and Johnson & Johnson, Inc. seeking compensation for injuries caused by failures of Raylene's DePuy ASR XL Acetabular Hip Replacement Systems that have been recalled. John David Hart of the Law Offices of John David Hart in Fort Worth, Texas, is the attorney representing Raylene and Michael Riha in the lawsuit filed in the United States District Court for the Southern District of Texas in Houston.

In October 2008, Ms. Riha underwent hip replacement surgery to have a DePuy ASR XL Acetabular System implanted in her left hip. In May 2009, she underwent hip replacement surgery again and another ASR XL Acetabular System was implanted in her right hip. Since the surgical implantation of the ASR XL Acetabular Systems in both hips, she has suffered severe and debilitating injuries. As a result, on October 11, 2010, she was required to have surgery to remove the DePuyASR XL Acetabular System from her right hip and revise it with another system.

"Raylene Riha is a 53 year-old woman who would never have elected to have the ASR XL hip system implanted in both of her hips had she known that the devices weren't safe or effective," said attorney Hart. "She has already undergone one revision surgery to replace the failed device in her right hip and faces the potential for revision surgery on her left hip in the future. The consequences of these failed, recalled devices have been extensive and devastating for Raylene and Michael."

DePuy Orthopaedics, Inc., a division of Johnson & Johnson, Inc., recalled its ASR XL Acetabular metal-on-metal hip replacement system on August 24, 2010. This recall came after data from a recent study indicated that the five year failure rate of this product is approximately 13%, or more than 1 out of every 8 patients. DePuy identified reasons for the failure of the hip replacement system as component loosening, component malalignment, infection, fracture of the bone, dislocation, metal sensitivity and pain. Additional complications from the DePuy ASR XL Acetabular Hip Replacement System may include increased metal ion levels in the blood, bone staining, necrosis, swelling, nerve damage, tissue damage and/or muscle damage. This device was marketed by DePuy Orthopaedics as a high performance hip replacement system.

John David Hart and the Law Offices of John David Hart represent many individuals in the United States who have been injured as a result of this defective hip replacement system. The Law Offices of John David Hart is a group of experienced and dedicated legal professionals working to protect the rights of people wronged by the acts of others. Across the country, the firm represents individuals in cases of catastrophic personal injury, wrongful death, dangerous drugs, automobile and truck accidents and oil and gas litigation. For more information, please contact John David Hart at 800.961.4278 or johnhart@hartlaw.com.

Law Offices of John David Hart

Lithium vs. Palladium - Zwei Rohstoff-Chancen traden
In diesem kostenfreien PDF-Report zeigt Experte Carsten Stork interessante Hintergründe zu den beiden Rohstoffen inkl. . Zudem gibt er Ihnen konkrete Produkte zum Nachhandeln an die Hand, inkl. WKNs.
Hier klicken
© 2011 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.